• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Past marijuana exposure linked to impaired verbal memory

byJames EnglandandAnees Daud
February 4, 2016
in Chronic Disease, Public Health
Reading Time: 2 mins read
Past marijuana exposure linked to impaired verbal memory
Share on FacebookShare on TwitterShare on LinkedIn

1. Based on observational data, cumulative lifetime marijuana exposure was associated with worse performance on verbal memory testing, but not processing speed or executive function testing.

2. Verbal memory worsened in a dose-dependent manner, with a step-wise decrease in memory for each additional 5 marijuana-years of exposure (1825 days of use).

Evidence Rating Level: 2 (Good)

Study Rundown: Marijuana use is common amongst the American adolescent and young adult population, but evidence on long-term health outcomes is currently lacking. The described study used data from a cohort of young adults aged 18 to 30 with a 25-year follow-up. Survey data from the cohort was used to assess for marijuana and other drug exposure, as well as other psychiatric comorbidities, and cardiovascular risk factors. Cognition was formally assessed at 25-year follow up using examinations of verbal memory, processing speed, and executive function.

The results of the study showed that prior exposure to marijuana was associated with decreased performance on verbal memory testing, but not processing speed or executive function testing. Additionally, verbal memory worsened in a dose-dependent manner, with a step-wise decrease in memory for each additional 5 marijuana-years of exposure (1825 days of use). The strengths of the study included a large cohort size, long follow-up, and data on possibly confounding comorbid conditions and demographics. Limitations of the study included reliance on self-reported exposures, using different tests to interpret cognitive function at the beginning compared to the end of the observational period, and only evaluating cognitive function at one follow up time period rather than at regular intervals.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

The Scan by 2 Minute Medicine®: Vampire Facials: HIV in Pursuit of Beauty, Fentanyl Awareness Day, Marijuana Reclassification: Cannabis Restrictions to Ease?, Menopause Meds: A Safe Passage

The Scan by 2 Minute Medicine®: A Misconception about Miscarriage, Scandal and ADHD, 10000 Steps per Day and Marijuana During Pregnancy!

Relevant Reading: Persistent cannabis users show neuropsychological decline from childhood to midlife

In-Depth [prospective cohort]: This study used data from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort, which comprised of 5115 adults aged 18 to 30 from March 25, 1985 to June 7, 1986. The CARDIA cohort was followed up at 2, 5, 7, 10, 15, 20, and 25 years with assessment of cardiovascular risk factors, drug and alcohol use, physical activity, and psychiatric disorders. A total of 3385 patients were followed for 25 years, of which 84.3% reported prior marijuana exposure. Initial cognitive function was assessed at 2-years using a “mirror star tracing test” and at 25-years using three different formal assessments of verbal memory, processing speed, and executive function.

After excluding participants with current marijuana use or self reported history of schizophrenia, linear regression analysis was performed. Lifetime exposure to marijuana was associated with decreased performance on verbal memory testing (p = 0.02). Association was dependent on time of marijuana exposure: every 5 marijuana-years decreased performance by 0.13 (95%CI -0.24 to -0.02) standardized units. After controlling for possible confounders, no significant association was identified between past marijuana use and changes in executive function or processing speed.

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: marijuana
Previous Post

Antibiotics not linked to improved recovery in acute malnutrition

Next Post

Metformin linked to reduced weight gain and improved insulin sensitivity in obese pregnant women without diabetes

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Vampire Facials: HIV in Pursuit of Beauty, Fentanyl Awareness Day, Marijuana Reclassification: Cannabis Restrictions to Ease?, Menopause Meds: A Safe Passage

May 14, 2024
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: A Misconception about Miscarriage, Scandal and ADHD, 10000 Steps per Day and Marijuana During Pregnancy!

October 4, 2022
Parental cannabis use increasing, cigarette use decreasing
Chronic Disease

Medical cannabis provides little improvement to sleep in chronic pain patients

July 6, 2022
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Wellness

Wellness Check: Sleep

July 6, 2022
Next Post
Diet and physical activity promotion associated with decreased risk of type 2 diabetes

Metformin linked to reduced weight gain and improved insulin sensitivity in obese pregnant women without diabetes

Proton radiotherapy for pediatric medulloblastoma demonstrates acceptable toxicity in phase 2 study

Proton radiotherapy for pediatric medulloblastoma demonstrates acceptable toxicity in phase 2 study

Unenhanced magnetic resonance imaging highly sensitive and specific for acute appendicitis

Unenhanced magnetic resonance imaging highly sensitive and specific for acute appendicitis

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
  • Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.